---
title: "Olema Pharmaceuticals slides 8% to 52-week low"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302897433.md"
description: "Olema Pharmaceuticals fell 7.98% to US$6.460. Down 17.26% over ten sessions and down 74.12% YTD."
datetime: "2026-10-23T15:55:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302897433.md)
  - [en](https://longbridge.com/en/news/302897433.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302897433.md)
generator: "portal-rs"
---

# Olema Pharmaceuticals slides 8% to 52-week low

Olema Pharmaceuticals (OLMA.US) slid nearly **8%** during regular trading to **$6.46**, hitting a 52-week low.

The stock is down 17.26% over the past ten sessions and down 74.12% year to date. It sits 82.18% below its 52-week high of US$36.25.

The Nasdaq Composite is down 0.27% over the past five sessions and up 12.16% year to date.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [OLMA.US](https://longbridge.com/en/quote/OLMA.US.md)

## Related News & Research

- [Olema Pharmaceuticals (OLMA) Receives a Rating Update from a Top Analyst](https://longbridge.com/en/news/299604966.md)
- [Is SoundHound AI (SOUN) Above Fair Value After New Deals?](https://longbridge.com/en/news/304688275.md)
- [Microsoft plans to use fewer neoclouds as AI buildout shows signs of strain](https://longbridge.com/en/news/304679878.md)
- [Oracle Announces Annual Meeting of Stockholders](https://longbridge.com/en/news/304689949.md)
- [Subgen AI consolidates AI operations under Substrate AI subsidiary](https://longbridge.com/en/news/304673508.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**